Transforming growth factor-β transiently induces vimentin expression and invasive capacity in a canine mammary gland tumor cell line

被引：15

作者：

Yoshida, K. ^{[1
]}

Saito, T. ^{[1
]}

Kamida, A. ^{[1
]}

Matsumoto, K. ^{[1
]}

Saeki, K. ^{[1
]}

Mochizuki, M. ^{[1
]}

Sasaki, N. ^{[1
]}

Nakagawa, T. ^{[1
]}

机构：

[1] Univ Tokyo, Lab Vet Surg, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan

来源：

RESEARCH IN VETERINARY SCIENCE | 2013年 / 94卷 / 03期

关键词：

Dog; Mammary gland tumor; EMT; TGF-beta; MET; xCELLigence RTCA; EPITHELIAL-MESENCHYMAL TRANSITIONS; TGF-BETA; IN-VITRO; PROGRESSION; NEOPLASMS; CANCER;

D O I：

10.1016/j.rvsc.2012.10.016

中图分类号：

S85 [动物医学（兽医学）];

学科分类号：

0906 ;

摘要：

The epithelial-mesenchymal transition (EMT) is a crucial event that occurs during cancer metastasis and can be induced by transforming growth factor-beta (TGF-beta) in various tumor cells in vitro. However, little is known about the effects of TGF-beta in canine mammary gland tumors (CMGTs). Here, we investigated the role of TGF-beta in CMGT. We observed that treatment of the CMGT cell line CHMp13a with TGF-beta 1 leads to transient induction of the mesenchymal marker vimentin. Real-time measurements of cellular electrical impedance also showed that CMGT invasiveness is transiently increased by TGF-beta 1 treatment, but is reversed after prolonged stimulation. This phenomenon is similar to the mesenchymal-epithelial transition (MET, the reverse phenomenon of EMT), and a process that is implicated in the establishment of secondary metastatic lesions. (C) 2012 Elsevier Ltd. All rights reserved.

引用

页码：539 / 541

页数：3

共 50 条

[21] Transforming growth factor-β signaling at the tumor-bone interface promotes mammary tumor growth and osteoclast activation
Futakuchi, Mitsuru
Nannuru, Kalyan C.
Varney, Michelle L.
Sadanandam, Anguraj
Nakao, Kimihisa
Asai, Kiyofumi
Shirai, Tomoyuki
Sato, Shin-ya
Singh, Rakesh K.
CANCER SCIENCE, 2009, 100 (01) : 71 - 81
[22] Expression of transforming growth factor-β and tumor necrosis factor-α in the plasma and tissues of mice with lupus nephritis
Yamamoto, K
Loskutoff, DJ
LABORATORY INVESTIGATION, 2000, 80 (10) : 1561 - 1570
[23] Transforming growth factor-α mRNA and epidermal growth factor receptor mRNA expression in normal and neoplastic mammary glands of four strains of mice with different mammary tumor potentials
Tsunoda, S
Ikezaki, Y
Nagasawa, H
ZOOLOGICAL SCIENCE, 1997, 14 (05) : 803 - 807
[24] Transforming growth factor-β1 induces tumor stroma and reduces tumor infiltrate in cervical cancer
Hazelbag, S
Gorter, A
Kenter, GG
Van den Broek, L
Fleuren, G
HUMAN PATHOLOGY, 2002, 33 (12) : 1193 - 1199
[25] Transforming growth factor-β2 induces bronchial epithelial mucin expression in asthma
Chu, HW
Balzar, S
Seedorf, GJ
Westcott, JY
Trudeau, JB
Silkoff, P
Wenzel, SE
AMERICAN JOURNAL OF PATHOLOGY, 2004, 165 (04): : 1097 - 1106
[26] Transforming growth factor-β induces the expression of vascular endothelial growth factor through MAP kinase pathway
Han, J
Thakker, G
Zhou, X
Hajjar, DP
Rosengart, TK
Polce, DR
Nicolson, AC
CIRCULATION, 1999, 100 (18) : 405 - 405
[27] Enhancement of metastatic and invasive capacity of gastric cancer cells by transforming growth factor-β1
Wang, KS
Hu, ZL
Li, JH
Xiao, DS
Wen, JF
ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2006, 38 (03) : 179 - 186
[28] Enhancement of Metastatic and Invasive Capacity of Gastric Cancer Cells by Transforming Growth Factor-β1
Kuan-Song WANG
Acta Biochimica et Biophysica Sinica, 2006, (03) : 179 - 186
[29] Tumour-stromal interactions: Transforming growth factor-β isoforms and hepatocyte growth factor/scatter factor in mammary gland ductal morphogenesis
Jeffrey W Pollard
Breast Cancer Research, 3
[30] Tumour-stromal interactions -: Transforming growth factor-β isoforms and hepatocyte growth factor/scatter factor in mammary gland ductal morphogenesis
Pollard, JW
BREAST CANCER RESEARCH, 2001, 3 (04) : 230 - 237

← 1 2 3 4 5 →